March 4, 2020
by Irina Bilous
Biopharma insight
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs …
Feb. 19, 2020
by Irina Bilous
Biopharma insight
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
Feb. 17, 2020
by Rasim Shah
Biopharma insight
As we enter a new decade, our belief in the the impact of Artificial intelligence (AI) is only getting stronger. …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
Feb. 6, 2020
by Caroline Green
Biopharma insight
In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric …
Feb. 4, 2020
by Peter Jarowski
Biopharma insight
Chemical Data Has Problems The state of data access, quality and dissemination in Chemistry is extremely poor - so poor …
Jan. 28, 2020
by Andrii Buvailo
Interview
Computer-aided drug design (CADD) is a central part of so-called “rational drug design”, pioneered in the last century by companies …
Jan. 2, 2020
by Andrii Buvailo
Biopharma insight
There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …
Dec. 24, 2019
by Andrii Buvailo
Biopharma insight
/Last update -- 24 Dec 2019/ A background context -- opportunities and challenges Current widespread interest towards artificial intelligence (AI) and …
Dec. 18, 2019
by Andrii Buvailo
Interview
The application of artificial intelligence (AI) in the pharmaceutical industry has become a long-term strategic priority for most companies. However, …
Nov. 13, 2019
by Allie Cooper
Biopharma insight
As mentioned in our post, ‘13 Useful Mobile Apps For Life Scientists’, mobile devices have become widespread, and different mobile …
Nov. 6, 2019
by Andrii Buvailo
Interview
Variational AI is a newly formed artificial intelligence (AI)-driven molecule discovery & drug design startup out of Vancouver, British Columbia, …